Differential expression of circRNA in placenta of patients with gestational hypertension and its potential mechanism
LV Jungang1, ZHAI Li1, LIU Jinlong2,3, ZHANG Lin1, WANG Na1, PANG Aibo4, YAN Zhifeng2
1. The Third Department of Internal Medicine, Beijing Minicipal Corps Hospital of Chinese People's Armed Police Force, Beijing 100027, China; 2. Department of Obstetrics and Gynecology, the First Medical Center of PLA General Hospital, Beijing 100853, China; 3. Characteristics Medical Center of Chinese People's Armed Police Force, Tianjin 300162, China; 4. PLA Medical School, Beijing 100853, China
Abstract:Objective To detect the difference of circular RNA (circRNA) expression in placentas between patients with gestational hypertension and healthy women based on high-throughput sequencing, and to explore the pathogenesis of gestational hypertension. Methods Six pregnant women with gestational hypertension admitted to the First Medical Center of PLA General Hospital from February 2018 to December 2018 were selected as the research objects (group M), and six healthy pregnant women in the same period were selected as the control group (group C). Placental tissues from patients in group M and group C were sequenced after quality control using BWA-MEM, circRNAs were identified using CIRI2, and the source of circRNAs was determined. CircRNA differential expression analysis was performed using DEGseq. The target miRNA of circRNA was predicted by miRanda software and miRBase sequence of this species, and the corresponding mRNA was predicted by Targetscan database. GO and KEGG enrichment analysis were performed on the differentially expressed circRNA target genes, and the genes were imported into String online database for cluster analysis, and the genes at the core of the network were searched. Results There were 31 differential circRNAs in the two groups of samples, 14 down-regulated and 17 up-regulated, among which the first five up-regulated circRNAs were circRNA00809, circRNA00593, circRNA00166, circRNA00184 and circRNA00028 respectively, and the first five down-regulated circRNAs were circRNA00520, circRNA00714, circRNA02491, circRNA00841 and circRNA01454 respectively. GO enrichment analysis showed that the main biological process of enrichment was reproduction process. The main enriched cell component was extracellular region. The main enriched molecular function was electron transfer activity. Metabolism was the most involved in the enrichment of KEGG pathway. Interaction network analysis showed that NOTCH1/2 was at the core. Conclusions The differential expression of 31 circRNAs in placenta is associated with gestational hypertension, which may play a role by regulating metabolic pathways, and NOTCH1/2 and other genes are at the center of regulatory network.
吕俊刚, 翟莉, 刘金龙, 张琳, 王娜, 逄瑷博, 闫志风. 妊娠期高血压患者胎盘组织中circRNA 表达差异及其潜在作用机制[J]. 武警医学, 2024, 35(4): 329-334.
LV Jungang, ZHAI Li, LIU Jinlong, ZHANG Lin, WANG Na, PANG Aibo, YAN Zhifeng. Differential expression of circRNA in placenta of patients with gestational hypertension and its potential mechanism. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(4): 329-334.
Lewandowska M, Więckowska B, Sajdak S, et al. Pre-Pregnancy obesity vs. other risk factors in probability models of preeclampsia and gestational hypertension[J]. Nutrients, 2020,12(9):512-522
Deng N, Lei D, Huang J, et al. Circular RNA expression profiling identifies hsa_circ_0011460 as a novel molecule in severe preeclampsia[J]. Pregnancy Hypertens, 2019,17(5):216-225.
Jiang M, Lash G E, Zhao X, et al. CircRNA-0004904, CircRNA-0001855, and PAPP-A: potential novel biomarkers for the prediction of preeclampsia[J]. Cell Physiol Biochem, 2018,46(6):2576-2586.
Zhu H, Niu X, Li Q, et al. Circ_0085296 suppresses trophoblast cell proliferation, invasion, and migration via modulating miR-144/E-cadherin axis[J]. Placenta, 2020,97(1):18-25.
[20]
Zhang C, Hu J, Yu Y. CircRNA is a rising star in researches of ocular diseases[J]. Front Cell Dev Biol, 2020,8(2):850-861.
Prameswari N, Irwinda R, Wibowo N, et al. Maternal amino acid status in severe preeclampsia: a cross-sectional study[J]. Nutrients, 2022,14(5):501-509.
Moraes J, Behura S K, Geary T W, et al. Analysis of the uterine lumen in fertility-classified heifers: I. Glucose, prostaglandins, and lipids?[J]. Biol Reprod, 2020,102(2):456-474.
[17]
Deng N, Lei D, Huang J, et al. Circular RNA expression profiling identifies hsa_circ_0011460 as a novel molecule in severe preeclampsia[J]. Pregnancy Hypertens, 2019,17(5):216-225.
[23]
Gardner D K. Lactate production by the mammalian blastocyst: manipulating the microenvironment for uterine implantation and invasion?[J]. Bioessays, 2015,37(4):364-371.
[18]
Jiang M, Lash G E, Zhao X, et al. CircRNA-0004904, CircRNA-0001855, and PAPP-A: potential novel biomarkers for the prediction of preeclampsia[J]. Cell Physiol Biochem, 2018,46(6):2576-2586.
[24]
Frolova A I, O’Neill K, Moley K H. Dehydroepiandrosterone inhibits glucose flux through the pentose phosphate pathway in human and mouse endometrial stromal cells, preventing decidualization and implantation[J]. Mol Endocrinol, 2011,25(8):1444-1455.
[19]
Zhu H, Niu X, Li Q, et al. Circ_0085296 suppresses trophoblast cell proliferation, invasion, and migration via modulating miR-144/E-cadherin axis[J]. Placenta, 2020,97(1):18-25.
[20]
Zhang C, Hu J, Yu Y. CircRNA is a rising star in researches of ocular diseases[J]. Front Cell Dev Biol, 2020,8(2):850-861.
[25]
Hirschmugl B, Perazzolo S, Sengers B G, et al. Placental mobilization of free fatty acids contributes to altered materno-fetal transfer in obesity[J]. Int J Obes (Lond), 2021,21(4):378-389.
[21]
Prameswari N, Irwinda R, Wibowo N, et al. Maternal amino acid status in severe preeclampsia: a cross-sectional study[J]. Nutrients, 2022,14(5):501-509.
[26]
Uken K L, Schäff C T, Vogel L, et al. Modulation of colostrum composition and fatty acid status in neonatal calves by maternal supplementation with essential fatty acids and conjugated linoleic acid starting in late lactation[J]. J Dairy Sci, 2021,14(5):128-136.
[22]
Moraes J, Behura S K, Geary T W, et al. Analysis of the uterine lumen in fertility-classified heifers: I. Glucose, prostaglandins, and lipids?[J]. Biol Reprod, 2020,102(2):456-474.
[27]
Ou Y, Zhu L, Wei X, et al. Circular RNA circ_0111277 attenuates human trophoblast cell invasion and migration by regulating miR-494/HTRA1/Notch-1 signal pathway in pre-eclampsia[J]. Cell Death Dis, 2020,11(6):479-490.
[23]
Gardner D K. Lactate production by the mammalian blastocyst: manipulating the microenvironment for uterine implantation and invasion?[J]. Bioessays, 2015,37(4):364-371.
[28]
Vanaroj P, Chaijaroenkul W, Na-Bangchang K. Notch signaling in the pathogenesis, progression and identification of potential targets for cholangiocarcinoma (Review)[J]. Mol Clin Oncol, 2022,16(3):66-74.
[24]
Frolova A I, O’Neill K, Moley K H. Dehydroepiandrosterone inhibits glucose flux through the pentose phosphate pathway in human and mouse endometrial stromal cells, preventing decidualization and implantation[J]. Mol Endocrinol, 2011,25(8):1444-1455.
[29]
Hamada Y, Hiroe T, Suzuki Y, et al. Notch2 is required for formation of the placental circulatory system, but not for cell-type specification in the developing mouse placenta[J]. Differentiation, 2007,75(3):268-278.
[30]
Liu J J, Zhang L, Zhang F F, et al. Influence of miR-34a on preeclampsia through the Notch signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2019,23(3):923-931.
[25]
Hirschmugl B, Perazzolo S, Sengers B G, et al. Placental mobilization of free fatty acids contributes to altered materno-fetal transfer in obesity[J]. Int J Obes (Lond), 2021,21(4):378-389.
[26]
Uken K L, Schäff C T, Vogel L, et al. Modulation of colostrum composition and fatty acid status in neonatal calves by maternal supplementation with essential fatty acids and conjugated linoleic acid starting in late lactation[J]. J Dairy Sci, 2021,14(5):128-136.
[27]
Ou Y, Zhu L, Wei X, et al. Circular RNA circ_0111277 attenuates human trophoblast cell invasion and migration by regulating miR-494/HTRA1/Notch-1 signal pathway in pre-eclampsia[J]. Cell Death Dis, 2020,11(6):479-490.
[28]
Vanaroj P, Chaijaroenkul W, Na-Bangchang K. Notch signaling in the pathogenesis, progression and identification of potential targets for cholangiocarcinoma (Review)[J]. Mol Clin Oncol, 2022,16(3):66-74.
[29]
Hamada Y, Hiroe T, Suzuki Y, et al. Notch2 is required for formation of the placental circulatory system, but not for cell-type specification in the developing mouse placenta[J]. Differentiation, 2007,75(3):268-278.
[30]
Liu J J, Zhang L, Zhang F F, et al. Influence of miR-34a on preeclampsia through the Notch signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2019,23(3):923-931.